Abstract
Transgenic technology allows a gene of interest to be introduced into the genome of a laboratory animal, and provides an extremely powerful tool to dissect the molecular mechanisms of disease. Transgenic mouse models made by microinjection of DNA into zygotic pronuclei in particular have been widely used by the genetics community for 30 years. However, it remains a rather crude approach: injected sequences randomly insert in multiple copies as concatamers, they can be mutagenic, and they have variable or silenced expression depending on the site of integration, a phenomenon called position effects. As a result, multiple lines are required in order to confirm appropriate transgene expression. This can be partially overcome by flanking transgenes with insulator sequences to protect the transgene from the influence of the surrounding regulatory elements. Large (<300 kb) BAC-based transgenic vectors have also been shown to be more resistant to position effects. However, animals carrying extra copies of fairly large regions of the genome could have unpredictable phenotypes. The most effective method used to control for position effects is to target transgene insertion to specific genomic loci, the so-called targeted transgenesis; for instance, the fast, site-specific transgenic technology Targatt™. The purpose of this review is to provide an overview on the current existing methods for making targeted transgenic mouse models.
Similar content being viewed by others
References
Evans MJ, Kaufman MH (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154–156
Thomas KR, Capecchi MR (1987) Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51:503–512
Anastassiadis K, Glaser S, Kranz A et al (2010) A practical summary of site-specific recombination, conditional mutagenesis, and tamoxifen induction of CreERT2. Methods Enzymol 477:109–123
Kranz A, Fu J, Duerschke K et al (2010) An improved Flp deleter mouse in C57Bl/6 based on Flpo recombinase. Genesis 48:512–520
Raymond CS, Soriano P (2007) High-efficiency FLP and PhiC31 site-specific recombination in mammalian cells. PLoS ONE 2:e162
Groth AC, Olivares EC, Thyagarajan B et al (2000) A phage integrase directs efficient site-specific integration in human cells. Proc Natl Acad Sci USA 97:5995–6000
Keravala A, Groth AC, Jarrahian S et al (2006) A diversity of serine phage integrases mediate site-specific recombination in mammalian cells. Mol Genet Genomics 276:135–146
Ma QW, Sheng HQ, Yan JB et al (2006) Identification of pseudo attP sites for phage phiC31 integrase in bovine genome. Biochem Biophys Res Commun 345:984–988
Groth AC, Fish M, Nusse R et al (2004) Construction of transgenic Drosophila by using the site-specific integrase from phage phiC31. Genetics 166:1775–1782
Venken KJ, He Y, Hoskins RA et al (2006) P[acman]: a BAC transgenic platform for targeted insertion of large DNA fragments in D. melanogaster. Science 314:1747–1751
Bischof J, Maeda RK, Hediger M et al (2007) An optimized transgenesis system for Drosophila using germ-line-specific phiC31 integrases. Proc Natl Acad Sci USA 104:3312–3317
Olivares EC, Hollis RP, Chalberg TW et al (2002) Site-specific genomic integration produces therapeutic Factor IX levels in mice. Nat Biotechnol 20:1124–1128
Hollis RP, Stoll SM, Sclimenti CR et al (2003) Phage integrases for the construction and manipulation of transgenic mammals. Reprod Biol Endocrinol 1:79
Belteki G, Gertsenstein M, Ow DW et al (2003) Site-specific cassette exchange and germline transmission with mouse ES cells expressing phiC31 integrase. Nat Biotechnol 21:321–324
Sangiorgi E, Shuhua Z, Capecchi MR (2008) In vivo evaluation of PhiC31 recombinase activity using a self-excision cassette. Nucleic Acids Res 36:e134
Tasic B, Hippenmeyer S, Wang C et al (2011) Site-specific integrase- mediated transgenesis in mice via pronuclear injection. Proc Natl Acad Sci USA 108:7902–7907
Hippenmeyer S, Youn YH, Moon HM et al (2010) Genetic mosaic dissection of Lis1 and Ndel1 in neuronal migration. Neuron 68:695–709
Tasic B, Miyamichi K, Hippenmeyer S et al (2012) Extensions of MADM (mosaic analysis with double markers) in mice. PLoS ONE 7:e33332
Fan X, Petitt M, Gamboa M et al (2012) Transient, inducible, placenta-specific gene expression in mice. Endocrinology 153:5637–5644
Turan S, Galla M, Ernst E et al (2011) Recombinase-mediated cassette exchange (RMCE): traditional concepts and current challenges. J Mol Biol 407:193–221
Ohtsuka M, Ogiwara S, Miura H et al (2010) Pronuclear injection-based mouse targeted transgenesis for reproducible and highly efficient transgene expression. Nucleic Acids Res 38:e198
Brinster RL, Braun RE, Lo D et al (1989) Targeted correction of a majorhistocompatibility class II E alpha gene by DNA microinjected into mouse eggs. Proc Natl Acad Sci USA 86:7087–7091
Geurts AM, Cost GJ, Freyvert Y et al (2009) Knockout rats via embryo microinjection of zinc-finger nucleases. Science 325:433
Geurts AM, Cost GJ, Rémy S et al (2010) Generation of gene-specific mutated rats using zinc-finger nucleases. Methods Mol Biol 597:211–225
Tesson L, Usal C, Ménoret S et al (2011) Knockout rats generated by embryo microinjection of TALENs. Nat Biotechnol 29:695–696
Meyer M, de Angelis MH, Wurst W et al (2010) Gene targeting by homologous recombination in mouse zygotes mediated by zinc-finger nucleases. Proc Natl Acad Sci USA 107:15022–15026
Cui X, Ji D, Fisher DA et al (2011) Targeted integration in rat and mouse embryos with zinc-finger nucleases. Nat Biotechnol 29:64–67
Wefer B, Meyer M, Ortiz O et al (2013) Direct production of mouse disease models by embryo microinjection of TALENs and oligodeoxynucleotides. Proc Natl Acad Sci USA 110:3782–3787
Cong L, Ran FA, Cox D et al (2013) Multiplex genome engineering using CRISPR/Cas systems. Science 339:819–823
Mali P, Yang L, Esvelt KM et al (2013) RNA-guided human genome engineering via Cas9. Science 339:823–826
Jinek M, Chylinski K, Fonfara I et al (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337:816–821
Gasiunas G, Barrangou R, Horvath P et al (2012) Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci USA 109:e2579
Garneau JE, Dupuis MÈ, Villion M et al (2010) The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468:67–71
Chang N, Sun C, Gao L et al (2013) Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos. Cell Res 23:465–472
Wang H, Yang H, Shivalila CS et al (2013) One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153:910–918
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Chen-Tsai, R.Y., Jiang, R., Zhuang, L. et al. Genome editing and animal models. Chin. Sci. Bull. 59, 1–6 (2014). https://doi.org/10.1007/s11434-013-0032-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11434-013-0032-5